Stockreport

A Look at Compass Therapeutics (CMPX) Valuation Following Strong CTX-10726 Preclinical Data and Management Update [Yahoo! Finance]

Compass Therapeutics, Inc.  (CMPX) 
PDF Compass Therapeutics (CMPX) drew fresh attention after preclinical data for CTX-10726 were presented at SITC 2025. The data highlighted anti-tumor activity and a distinc [Read more]